Boiron: 2022 earnings up 56.4%

(CercleFinance.com) - The pharmaceutical laboratory Boiron has reported sales of E534m for 2022, up 17.
4% compared to 2021.

It's operating profit rose by 35.5% to 63 million euros, while net profit (group share) amounted to 44.6 million euros, up 56.4% y-o-y.

In 2023, the group's sales growth will potentially be impacted by the decline in sales of COVID tests, tensions on the supply of raw materials and energy, and by the geopolitical situation in certain regions of the world, it said.


Copyright (c) 2023 CercleFinance.com. All rights reserved.